HK1040906B - 用於治療癌症的無效igf - Google Patents
用於治療癌症的無效igfInfo
- Publication number
- HK1040906B HK1040906B HK02100514.5A HK02100514A HK1040906B HK 1040906 B HK1040906 B HK 1040906B HK 02100514 A HK02100514 A HK 02100514A HK 1040906 B HK1040906 B HK 1040906B
- Authority
- HK
- Hong Kong
- Prior art keywords
- cancer
- treatment
- igf
- null igf
- null
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 4
- 201000011510 cancer Diseases 0.000 title abstract 4
- 238000000034 method Methods 0.000 abstract 1
- 102000005962 receptors Human genes 0.000 abstract 1
- 108020003175 receptors Proteins 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Molecular Biology (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10274798P | 1998-10-02 | 1998-10-02 | |
US09/399,120 US7288516B1 (en) | 1999-09-20 | 1999-09-20 | Null IGF for the treatment of cancer |
PCT/US1999/022681 WO2000020023A2 (en) | 1998-10-02 | 1999-09-29 | Null igf for the treatment of cancer |
Publications (2)
Publication Number | Publication Date |
---|---|
HK1040906A1 HK1040906A1 (en) | 2002-06-28 |
HK1040906B true HK1040906B (zh) | 2005-12-09 |
Family
ID=26799690
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK02100514.5A HK1040906B (zh) | 1998-10-02 | 2002-01-23 | 用於治療癌症的無效igf |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1117424B1 (zh) |
JP (1) | JP2003522110A (zh) |
AT (1) | ATE303159T1 (zh) |
AU (1) | AU767141B2 (zh) |
CA (1) | CA2345353C (zh) |
DE (1) | DE69927041T2 (zh) |
HK (1) | HK1040906B (zh) |
WO (1) | WO2000020023A2 (zh) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030069177A1 (en) | 2000-05-16 | 2003-04-10 | Genentech, Inc. | Method for treating cartilage disorders |
EP1141014B1 (en) | 1999-01-06 | 2004-12-08 | Genentech, Inc. | Insulin-like growth factor (igf) i mutant variant |
WO2002024216A2 (en) | 2000-09-19 | 2002-03-28 | Bioexpertise, Llc | Method for use of igf-binding protein for selective sensitization of target cells in vivo |
AUPR030900A0 (en) * | 2000-09-22 | 2000-10-12 | Queensland University Of Technology | Growth factor complex |
US7081454B2 (en) | 2001-03-28 | 2006-07-25 | Bristol-Myers Squibb Co. | Tyrosine kinase inhibitors |
US7312215B2 (en) | 2003-07-29 | 2007-12-25 | Bristol-Myers Squibb Company | Benzimidazole C-2 heterocycles as kinase inhibitors |
US20100316639A1 (en) | 2009-06-16 | 2010-12-16 | Genentech, Inc. | Biomarkers for igf-1r inhibitor therapy |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5310742A (en) * | 1992-11-30 | 1994-05-10 | Elias Alan N | Uses for thioureylenes |
WO1995016703A1 (en) * | 1993-12-15 | 1995-06-22 | Thomas Jefferson University | Igf-1 analogs |
US6015786A (en) * | 1997-02-25 | 2000-01-18 | Celtrix Pharmaceuticals, Inc. | Method for increasing sex steroid levels using IGF or IGF/IGFBP-3 |
-
1999
- 1999-09-29 CA CA002345353A patent/CA2345353C/en not_active Expired - Fee Related
- 1999-09-29 WO PCT/US1999/022681 patent/WO2000020023A2/en active IP Right Grant
- 1999-09-29 AT AT99950037T patent/ATE303159T1/de not_active IP Right Cessation
- 1999-09-29 EP EP99950037A patent/EP1117424B1/en not_active Expired - Lifetime
- 1999-09-29 DE DE69927041T patent/DE69927041T2/de not_active Expired - Fee Related
- 1999-09-29 AU AU62778/99A patent/AU767141B2/en not_active Ceased
- 1999-09-29 JP JP2000573382A patent/JP2003522110A/ja active Pending
-
2002
- 2002-01-23 HK HK02100514.5A patent/HK1040906B/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2345353C (en) | 2009-07-07 |
EP1117424B1 (en) | 2005-08-31 |
JP2003522110A (ja) | 2003-07-22 |
AU767141B2 (en) | 2003-10-30 |
EP1117424A2 (en) | 2001-07-25 |
DE69927041T2 (de) | 2006-06-14 |
AU6277899A (en) | 2000-04-26 |
WO2000020023A3 (en) | 2000-07-06 |
ATE303159T1 (de) | 2005-09-15 |
CA2345353A1 (en) | 2000-04-13 |
HK1040906A1 (en) | 2002-06-28 |
DE69927041D1 (de) | 2005-10-06 |
WO2000020023A2 (en) | 2000-04-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GEP20094798B (en) | (s,s)-reboxetine for treating chronic pain | |
WO1999057117A3 (de) | Indolderivate und deren verwendung zur behandlung von malignen und anderen, auf pathologischen zellproliferationen beruhenden erkrankungen | |
WO2004045523A3 (en) | Combination administration of an indolinone with a chemotherapeutic agent for cell proliferation disorders | |
AU3648597A (en) | Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents | |
AU2332288A (en) | Compounds having antiprogestational and anti-estrogenic activities for induction of labor and for termination of pregnancy, as well as for the treatment of gynaecological disorders | |
EP1190074A4 (en) | RECOMBINANT ANTI-CD40 ANTIBODIES AND ITS APPLICATIONS | |
BR9714523A (pt) | Tratamento de nefrite de lúpus com compostos anti-cd40l | |
CA2301032A1 (en) | A method of preventing or treating estrogen-dependent diseases and disorders | |
IL146125A0 (en) | Novel quinones as disease therapies | |
UA29466C2 (uk) | Фармацевтична композиція з антипухлинною активністю | |
ZA200110408B (en) | Methods for treating diabetes. | |
HK1040906A1 (en) | Null igf for the treatment of cancer. | |
GB9824437D0 (en) | Gene therapy | |
HK1014671A1 (en) | Meta substituted arylalkylamines and therapeutic and diagnostic uses thereof | |
AU3308099A (en) | Method for the treatment of pain, including chronic and female specific pain | |
AU1791497A (en) | At1 receptor antagonist for the stimulation of apoptosis | |
WO2000004153A3 (en) | Repression of cell transformation with human pea3 | |
WO2000037065A3 (en) | Endocrine therapy for breast cancer: combined treatment with tamoxifen plus alkyl pcdfs | |
AU6290398A (en) | Inclusion complexes in aqueous solution | |
MD743F1 (en) | Remedy for immunity system and hormonal homeostasis normalization | |
AU2346301A (en) | Use of parvoviruses for improving the general condition of tumour patients or patients having chronic or consumptive diseases | |
GB9818650D0 (en) | Therapeutic compounds and methods of making and using the same | |
NZ336321A (en) | Use of benzothiophene (raloxifene) for treating breast cancer | |
AU4918900A (en) | Interferon-beta use in the treatment of ewing's family of tumors | |
EP1043026A3 (en) | Melanoma therapy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
CHPA | Change of a particular in the register (except of change of ownership) | ||
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20090929 |